Insight

Jame Abraham: A Moving Target in the Era of Antibody-Drug Conjugates

Jame Abraham/my.clevelandclinic.org

Jul 14, 2025, 08:10

Jame Abraham: A Moving Target in the Era of Antibody-Drug Conjugates

Jame Abraham, Chairman and Professor of Department of Hematology and Medical Oncology at Cleveland Clinic, shared on LinkedIn about a recent paper by Marko Velimirovic published in JCO:

“Human Epidermal Growth Factor Receptor 2 Positivity a Moving Target in the Era of Antibody-Drug Conjugates.”

Authors: Marko Velimirovic and Jame Abraham

Read the full article.

Antibody-Drug

More posts featuring Jame Abraham.

Antibody drug conjugates cancer Jame Abraham JCO Marko Velimirovic OncoDaily Oncology

Hagop Kantarjian: Advances and Revolution in Adult ALL Therapy Over the Last Decade

FDA Priority Review Granted for TAR-200 After 82% Complete Response in BCG-Unresponsive Bladder Cancer

Top 10 Immunotherapy Fellowships and Grants to Watch in 2025

July Is Sarcoma Awareness Month: What You Need to Know

Pat Soon-Shiong: SARS-CoV-2 Infection Can Awaken Sleeping Cancer Cells

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023

Facebook

Youtube

Insight

Aug 3, 2025, 17:55

Jia Liu: DEP SN38 Early Phase Clinical Trial Results Published in JCO

Blog

Aug 3, 2025, 17:38

Pat Soon-Shiong: Trying Hard for the Cancer Community

Blog

Aug 3, 2025, 17:15

Support from Three Young Bakers - World Child Cancer

Science

Aug 3, 2025, 17:14

Jordan Gauthier: B-Cell Maturation Antigen CAR T-Cell Therapy for RRMM

Insight

Aug 3, 2025, 17:02

Dr. Bishal Gyawali – Challenging the Status Quo Award: Yvonne Awards 2025

Insight

Aug 3, 2025, 17:01

Hafsa Elmarrachi: Strategic Synthesis of Breakthrough Clinical Advances in Lung and GI Cancers Presented at ASCO 2022 and 2023

Science

Aug 3, 2025, 16:42

Myeloma Paper of the Day, August 3rd, Suggested by Robert Orlowski

Blog

Aug 3, 2025, 16:34

Nina Niu Sanford: Excited to See Harvey Mamon as Co-Chair of the NCI GI Steering Committee

Blog

Aug 3, 2025, 16:24

William Aird: What Determines the ESR?

Blog

Aug 3, 2025, 16:12

Angela Morabito's Talk at MGH for the American Lung Cancer Screening Initiative - Florez Lab

Blog

Aug 3, 2025, 16:06

Bridging the Gap in the Diagnosis and Management of Lung Cancer - The Institute of Cancer and Crisis

Blog

Aug 3, 2025, 16:01

Amol Akhade: The Seduction of Significance